BRIEF published on 07/15/2025 at 08:05, 11 months 14 days ago Molten Ventures Executes Share Buyback Voting Rights Share Buyback Numis Securities Molten Ventures Stock Transactions
PRESS RELEASE published on 07/15/2025 at 08:00, 11 months 14 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces the purchase of 40,000 Ordinary Shares at 349.8070p each, as part of the share repurchase program Share Repurchase Molten Ventures Plc LSE GROW Numis Securities
BRIEF published on 07/14/2025 at 08:05, 11 months 15 days ago Molten Ventures Executes Share Repurchase Share Repurchase Market Abuse Regulation Numis Securities Molten Ventures Capital Management
PRESS RELEASE published on 07/14/2025 at 08:00, 11 months 15 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces share repurchase program results, with 3,584 shares purchased at prices between 344.00p and 345.60p on 11/07/2025 London Stock Exchange Share Repurchase GROW Numis Securities Molten Ventures
BRIEF published on 07/10/2025 at 08:05, 11 months 19 days ago Molten Ventures Executes Share Buyback Program Ordinary Shares Share Buyback Financial Conduct Authority Numis Securities Molten Ventures
PRESS RELEASE published on 07/10/2025 at 08:00, 11 months 19 days ago Transaction in Own Shares Molten Ventures Plc (GROW) announced a transaction in own shares, with Numis Securities purchasing 19,617 ordinary shares on 9 July 2025 at various prices. Company's total voting rights now at 180,647,323 Shares Molten Ventures Plc GROW Transaction Numis Securities
BRIEF published on 07/09/2025 at 08:05, 11 months 20 days ago Molten Ventures Announces Share Buyback Details Ordinary Shares Share Buyback Numis Securities Molten Ventures Market Regulation
PRESS RELEASE published on 07/09/2025 at 08:00, 11 months 20 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces transaction in own shares with purchase details and share capital update. Company active in venture capital investments Share Repurchase Molten Ventures Plc GROW Transaction Venture Capital
BRIEF published on 07/08/2025 at 14:05, 11 months 20 days ago Molten Ventures Plc Announces AGM Results Molten Ventures AGM Results Director Elections Auditor Reappointment Remuneration Approval
PRESS RELEASE published on 07/08/2025 at 14:00, 11 months 20 days ago Result of AGM Molten Ventures Plc announces successful results of the 2025 Annual General Meeting (AGM) with all resolutions passed. Company's ventures in high-growth digital tech sector Molten Ventures Plc Digital Technology Venture Capital Resolutions Passed 2025 AGM
Published on 06/29/2026 at 09:01, 2 hours 31 minutes ago HM Exploration Discovers New Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 06/27/2026 at 16:50, 1 day 18 hours ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 9 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 days 11 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 2 days 12 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/29/2026 at 11:03, 28 minutes ago PNE successful in onshore wind energy tender on May 1, 2026
Published on 06/29/2026 at 11:00, 31 minutes ago Original-Research: MustGrow Biologics Corp. (von GBC AG): BUY
Published on 06/29/2026 at 10:46, 46 minutes ago Aroundtown SA: Release of a capital market information
Published on 06/29/2026 at 10:35, 57 minutes ago Cherry SE Permanently Appoints Rogier Volmer as CEO, Committing to Continuity in Its Strategic Transformation
Published on 06/29/2026 at 10:56, 35 minutes ago GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
Published on 06/26/2026 at 07:00, 3 days 4 hours ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
